1-5 of 5
Min Bai
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Frontline brentuximab vedotin and PD-1 inhibitors in elderly Chinese Hodgkin lymphoma: Real-world survival benefits validated by geriatric and biomarker correlates

Free
Zhao Peiqi, Min Bai, Chen Huang, Jiesong Wang, Yajun Li, yanan Jiang, Ganggang Wang, Feng Zhu, Shu Zhao, Wei Guo, Shukai Qiao, Jianxia He, Ji Ma, Dong Song, Huixia Geng, Shaozhen Chen, Junqing Xu, Ou Bai, Hui Zhou, Qingyuan Zhang, Liping Su, Huilai Zhang
Journal: Blood
Blood (2025) 146 (Supplement 1): 1843.
https://doi.org/10.1182/blood-2025-1843
Published: 2025
Journal Articles

Mitoxantrone hydrochloride liposome (Lipo-MIT) combined with azacitidine and  Chidamide can be an effective chemotherapy regimen for patients with angioimmunoblastic T-cell lymphoma (AITL)

Free
Yanli Wang, Xuliang Shen, Guoxiang Zhang, Li Liang, Li Ma, Bing Xu, Jingrong Wang, Shaohua Wu, Min Bai, Xiaolian Wen, Le Li, Liping Su
Journal: Blood
Blood (2025) 146 (Supplement 1): 3652.
https://doi.org/10.1182/blood-2025-3652
Published: 2025
Journal Articles

A Prospective Investigator-Initiated Phase 1/2 Study of BCMA/CD19 Dual-Targeting CAR T Therapy in Patients with Relapsed/Refractory Multiple Myeloma Including Those with Extramedullary Disease

Free
Hua Jiang, Lu Li, Kaili Chen, Chunchen Yang, Ruixue Ma, Liangyu Xie, Can He, Fang Feng, Hao Wu, Xiaomei Chen, Dan Li, Xianghai Cai, Jin Zhao, Tao Guan, Li Ma, Min Bai, Guoxiang Wu, Liping Su, Weijun Fu
Journal: Blood
Blood (2024) 144 (Supplement 1): 923.
https://doi.org/10.1182/blood-2024-201160
Published: 2024
Journal Articles

Mitoxantrone Hydrochloride Liposome (Lipo-MIT) Combined with Azacitidine and Chidamide Can be an Effective Chemotherapy Regimen for Patients with Angioimmunoblastic T-Cell Lymphoma (AITL)

Free
Yanli Wang, Li Lang, Li Ma, Jingrong Wang, Shaohua Wu, Min Bai, Xuliang Shen, Xiaolian Wen, Le Li, Liping Su
Journal: Blood
Blood (2024) 144 (Supplement 1): 6514.
https://doi.org/10.1182/blood-2024-205043
Published: 2024
Journal Articles

Clinical Observation of Camrelizumab (CAM) Combined with Bendamustine and Gemcitabine (BeGe) in Relapsed/Refractory Classical Hodgkin Lymphoma (cHL): A Phase II Trial

Free
Min Bai, Li-Ping Su, Tao Guan
Journal: Blood
Blood (2023) 142 (Supplement 1): 4447.
https://doi.org/10.1182/blood-2023-185384
Published: 2023